SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
University of California, San Francisco
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
C17 Council
Memorial Sloan Kettering Cancer Center
Schrödinger, Inc.
Universitätsklinikum Hamburg-Eppendorf
Shanghai Exuma Biotechnology Ltd.
The First Affiliated Hospital of Soochow University